Delivery Order SPE2DB22D1103-SPE2DB25FH2B3
Award Date 9/10/25
Potential Completion Date 9/11/25
Potential Value $7.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,579.06 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injectors on September 2, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed at the contractor's Conshohocken, Pennsylvania location. Zepbound is a semaglutide-based medication indicated for weight management, and this procurement supports federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $14,239.24 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors on September 15, 2025, with completion targeted for September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide injection used for weight management and...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a ceiling value of $4,466.38. This is a firm fixed price delivery order under a competitive, non-set-aside procurement. The contract is set to be completed by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound (semaglutide) is a GLP-1 receptor...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injectors in 0.5 mL quantities, with a contract ceiling value of $32,050.85. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and...
- The Defense Logistics Agency awarded a delivery order valued at $10,048.41 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based pharmaceutical product used in diabetes and...
- The Defense Logistics Agency awarded a $13,150.18 delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pen injectors on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used for weight management, reflecting the federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,973.24 on July 31, 2025, for the supply of Zepbound 5 mg/0.5 mL pens (0.5 mL). This is a firm fixed-price delivery order with no set-aside designation, issued as a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with completion scheduled for August 1, 2025. Zepbound, a semaglutide...
- The Defense Logistics Agency awarded a $66,148.76 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based medication indicated for weight management, reflecting the agency's procurement needs for...
- The Defense Logistics Agency awarded a delivery order valued at $6,977.88 to AmerisourceBergen Drug Corp for ZEPBOUND 10 mg/0.5 ml pen auto-injectors on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed price, non-competitive delivery order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. ZEPBOUND is a semaglutide-based medication used for weight management in adults with obesity or overweight conditions,...
- The Defense Logistics Agency Medical Supply Chain awarded a $14,214.34 delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections with a completion date of July 17, 2025. This is a firm fixed price, non-set-aside delivery order issued under a child contract arrangement, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location. Zepbound is a semaglutide-based pharmaceutical product used for weight...